LEHI, UT, and SOUTH SAN FRANCISCO, CA – March 16, 2022—Lumea, the global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, today announced a strategic…
Read More
Why hasn’t digital pathology taken hold, and will it ever be viable for routine work? Every pathologist knows we’re supposed to be entering the age of digital pathology, yet the...
Read More
TruCore Pathology is a team of board-certified, expert pathologists. They use Lumea’s proprietary tissue-handling technology to get larger, higher-quality samples that increase cancer detection. Lumea is advancing pathology into the…
Matthew Leavitt, MD, just co-founded the DDx Foundation. He aims to progress prostate cancer research and treatment through digital diagnostics. The other founders are pathologists E. David Crawford, MD, and…
Matthew Leavitt, MD, Lumea Founder, had the opportunity to speak at Cambridge Health Institute’s 7th annual Digital Pathology Conference. This Cambridge conference focused on transforming medicine in a digital world. “Seven…
PathNet uses Lumea digital pathology tech in its practices. PathNet is a coalition of independent pathology groups founded for pathologists by pathologists. Their united goal is to leverage Lumea’s digital…
